Genzyme : the Synvisc-One investment decision /

Executives at biotechnology firm Genzyme are debating funding a clinical trial for a new version of a medical device called Synvisc. The trial is expensive and the odds of success are not high, but the upside is substantial. The case presents a common business question: invest or not? The case force...

Full description

Bibliographic Details

Main Authors:	Calkins, Tim (Author), Deming, Ann (Author)
Corporate Author:	Sage Publications
Format:	eBook
Language:	English
Published:	[London] : SAGE, 2016.
Series:	SAGE knowledge. Cases.
Subjects:	Industrial management > Case studies. Risk management > Case studies. Electronic books.
Online Access:	Connect to the full text of this electronic book